IDEXX Laboratories/ US45168D1046 /
| 11/6/2024 9:59:56 PM | Chg. +7.55 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 423.43USD | +1.82% | 76,896 Turnover: 32.28 mill. |
-Bid Size: - | -Ask Size: - | 34.67 bill.USD | - | 41.63 |
Assets
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 303.5870 | 333.0260 | 357.4220 | 379.0960 | 437.2700 | ||||||
| Intangible Assets | 65.1220 | 55.9090 | 46.1550 | 43.8460 | 41.8250 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 624.8130 | 653.3590 | 685.1200 | 741.4310 | 883.1770 | ||||||
| Inventories | 160.3420 | 188.8330 | 158.0340 | 164.3180 | 173.3030 | ||||||
| Accounts Receivable | 152.3800 | 188.3180 | 204.4940 | 234.5970 | 248.8550 | ||||||
| Cash and Cash Equivalents | 322.5360 | 128.9940 | 154.9010 | 187.6750 | 123.7940 | ||||||
| Current Assets | 759.3980 | 821.6340 | 845.5840 | 971.9850 | 654.1720 | ||||||
| Total Assets | 1,384.2110 | 1,474.9930 | 1,530.7040 | 1,713.4160 | 1,537.3490 | ||||||
Liabilities
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 44.7430 | 52.6480 | 60.0570 | 66.9680 | 69.5340 | ||||||
| Long-term debt | 350 | 597.0850 | 593.1100 | 606.0750 | 601.3480 | ||||||
| Liabilities to Banks | 549 | 573 | 611 | 655 | 398.9000 | ||||||
| Provisions | 195.4000 | 205.5000 | 236.1000 | 253.4000 | 260.7000 | ||||||
| Liabilities | 1,266.6220 | 1,558.9880 | 1,638.9170 | 1,767.2580 | 1,546.5820 | ||||||
| Share Capital | 20.3900 | 10.2580 | 10.3340 | 10.4280 | 10.5090 | ||||||
| Total Equity | 117.5890 | -83.9950 | -108.2130 | -53.8420 | -9.2330 | ||||||
| Minority Interests | .0730 | .1300 | .1390 | .2640 | .2800 | ||||||
| Total liabilities equity | 1,384.2110 | 1,474.9930 | 1,530.7040 | 1,713.4160 | 1,537.3490 | ||||||
Income Statement
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,485.8070 | 1,601.8920 | 1,775.4230 | 1,969.0580 | 2,213.2420 | ||||||
| Depreciation (total) | 58.8880 | 68.9560 | - | - | - | ||||||
| Operating Result | 260.2550 | 299.9120 | 350.2390 | 413.0280 | 491.3350 | ||||||
| Interest Income | -13.7000 | -26.7710 | -28.3930 | -31.9710 | -33.5930 | ||||||
| Income Before Taxes | 246.5550 | 273.1410 | 321.8460 | 381.0570 | 457.7420 | ||||||
| Income Taxes | 64.6040 | 81.0060 | 99.7920 | 117.7880 | 80.6950 | ||||||
| Minority Interests Profit | .0450 | .0570 | .0090 | .1250 | .0160 | ||||||
| Net Income | 181.9060 | 192.0780 | 222.0450 | 263.1440 | 377.0310 | ||||||
Per Share
Cash Flow
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 235.8460 | 216.3640 | 334.5710 | 373.2760 | 400.0840 | ||||||
| Cash Flow from Investing Activities | -80.4130 | -308.4060 | -90.7860 | -138.6880 | 138.6020 | ||||||
| Cash Flow from Financing | -103.4380 | -95.5520 | -217.8240 | -208.0160 | -597.7990 | ||||||
| Decrease / Increase in Cash | 43.4780 | -193.5420 | 25.9070 | 32.7740 | -63.8810 | ||||||
| Employees | 6,400 | 6,800 | 7,365 | 7,600 | 8,377 | ||||||
